Skip to content

Michael R. Aaron, D.O.

NPI 1336129071ActiveIndividual· Internal Medicine, Cardiovascular Disease· Neptune, NJ

Internal Medicine, Cardiovascular Disease (D.O.) in Neptune, New Jersey, trained at New York College of Osteo Medicine of New York Institute of Technology (class of 1986). Their prescriptions cost Medicare Part D more than their services did: $1,465,179 for 9,320 claims, against $920,661 paid for services in 2024. Novartis Pharmaceuticals Corporation was the largest of 20 companies reporting payments in 2025, $1,668 in all, mostly food and beverage.

Overview

NPI1336129071
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorNo
NPI issuedJan 19, 2006
Last updated in NPPESDec 20, 2019
Certified by providerDec 20, 2019

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Cardiovascular Disease (Cardiology) (NJ)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients1,673
Services billed10,174 across 61 procedure codes
Paid by Medicare$920,661

Part D prescriptions in 2024

Prescriptions (claims)9,320 · 25,677 30-day fills
Patients1,146
Total drug cost$1,465,179
Generic share86% of claims

Medicare sources and data years

Education and affiliations

Medical schoolNew York College of Osteo Medicine of New York Institute of Technology
Graduation year1986
Medicare specialtyCardiovascular Disease (Cardiology)

Medical groups

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$1,668 · 121 payments from 20 companies
  • 2024$2,412 · 153 payments from 16 companies

Top paying companies in 2025

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$229.0826
Pfizer Inc.$204.2014
Abbott Laboratories$173.383
Amgen Inc.$166.6210
Novo Nordisk Inc$146.2412

What the 2025 payments were for

  • Food and Beverage$1,668 · 121 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Cardiovascular Disease providers in Neptune

All Internal Medicine, Cardiovascular Disease providers in New Jersey →